In the riverside towns of southern Bayelsa, where roads give way to mangrove creeks and mud-coloured channels, a malaria vaccine has begun to change the rhythm of childhood. Nigeria, the continent's most populous nation and a country that lost nearly 200,000 people to the disease in 2024 alone, has seen its first doses reach families who had long lived with fear of fever and seizures. The gains are real but partial, reaching a fraction of the nation's states and leaving open whether a promise made in a single clinic can be carried to every village that the boats still must reach.
Tears, Then Hope: Nigeria's Malaria Vaccine Rollout Reaches Remote Delta Villages
Malaria killed nearly 200,000 Nigerians and some 600,000 people worldwide in 2024, with children under five making up more than 75 per cent of African malaria deaths.
Rubber boots, a raincoat and an umbrella for the long trek ahead
Mark
Why does a story about a baby's cry matter on a national scale?
Mimi
Because Oruma shows what the vaccine can do locally. Officials there say no child deaths have been recorded since it arrived, and PATH reports an 18-percent drop in under-five infections in Bayelsa.
Luke
Careful, though. The 18 percent is PATH's figure, and the no-deaths claim is Elizabeth Ogisi's account for her area. The story doesn't give independent data, and Bayelsa's health ministry didn't respond.
Mark
So how far has the rollout actually got?
Mimi
Almost a quarter-million children fully vaccinated, 1.8 million jabs, in four of 36 states. Nigeria has 240 million people and 68.5 million infections a year.
Luke
Which means this is a small slice. The source doesn't say what share of eligible children that covers.
Mark
What about the cost to families?
Mimi
Ezibanyenami Paul said medicine costs 5,000 naira, about US$3.75, which is too much for her. A baby who never gets sick saves that.
Luke
That's one mother's experience. It's telling, but not a measure of household spending across Bayelsa.
Mark
And the boats and the umbrellas?
Mimi
They show the real obstacle is reach. Some zones have no roads, and workers gave jabs on home visits when parents missed appointments.
Luke
The vaccine's protection also fades and isn't complete, as PATH's Hadiza Hussayn Jibril said. Whether it holds up as it scales is still unknown.
Le Pouls
- Children in Oruma cry under the needle while clinic staff apologise, a small, painful price for a shot that may keep a fever from becoming a seizure.
- Nigeria has rolled out malaria jabs to almost a quarter-million fully vaccinated children, yet only four of its 36 states are covered so far.
- Health workers are pushing vaccines by boat into roadless zones, catching missed appointments through home visits where parents could not travel.
- Bayelsa reports an 18 per cent fall in malaria among under-fives, but the vaccine is not complete protection and cost and access barriers still press on families.
- Oil wealth flows past the communities while pipeline guards and underfunded health systems leave the next steps uncertain, with the real test being whether the rollout can reach the rest of the country.
In the riverside towns of southern Bayelsa, where roads give way to mangrove creeks and mud-coloured channels, a malaria vaccine has begun to change the rhythm of childhood. Nigeria, the continent's most populous nation and a country that lost nearly 200,000 people to the disease in 2024 alone, has seen its first doses reach families who had long lived with fear of fever and seizures. The gains are real but partial, reaching a fraction of the nation's states and leaving open whether a promise made in a single clinic can be carried to every village that the boats still must reach.
In the town of Oruma, in southern Bayelsa state, a needle goes in, a baby cries, and the clinic staff answer with a soft "sorry, sorry." Another child is counted as vaccinated against malaria, a disease that remains one of the hardest killers of children in Nigeria.
The world's first malaria vaccines reached Nigeria in late 2024, and hopes ran high. Progress has been slow since, but almost a quarter-million children are now fully vaccinated, and in some villages child deaths from the disease have stopped altogether.
Ezibanyenami Paul, a 24-year-old hairdresser, brought her daughter for the final dose. The girl cried; her mother smiled. Her infant has never had malaria, which matters to a family for whom treatment costs too much. Zuweira Nasiru's two-year-old son has had only mild cases since his vaccination.
Elizabeth Ogisi, a primary health director in Ogbia, remembers malaria as "rampant," progressing to seizures and sometimes death. Since the vaccine arrived, she says, no child deaths have been recorded.
The national picture is more modest. Only four of Nigeria's 36 states have the jabs. In Sagbama, James Kurofou describes roadless zones where staff travel by boat, and where home visits now catch the parents who could not make the trip to the clinic.
The effort sits against a harder backdrop. Oil wealth has not produced working health care, and fighting malaria depends on funding, medicines and drainage that the state has long lacked. The next test is whether the vaccine can travel beyond four states and into the places reachable only by water.
In the town of Oruma, in southern Bayelsa state, a needle goes in, a baby wails, and the clinic staff answer with a soft "sorry, sorry." Then another child is counted as vaccinated against malaria, a disease that remains one of the hardest child killers in Nigeria.
The world's first malaria vaccines reached Africa's most populous country in late 2024, and expectations were high. That year malaria killed nearly 200,000 Nigerians and some 600,000 people worldwide. Progress since has been slow. Still, almost a quarter-million Nigerian children are now fully vaccinated, and 1.8 million jabs have been given. In some villages, child deaths from the disease have stopped altogether.
Ezibanyenami Paul, a 24-year-old hairdresser, brought her daughter to Oruma for the fourth and final dose. The girl cried; her mother smiled. "It makes me feel happy," she said. Her infant has never had malaria, which matters because malaria medicine costs 5,000 naira, about US$3.75, and she says that is too expensive for a disease that is easy to treat. Zuweira Nasiru, 39, said her two-year-old son Abdulrauf, the first of her seven children to be vaccinated, has had only mild cases.
Health officials describe a change. Elizabeth Ogisi, director of primary health care for the Ogbia local government area, called the time before the vaccine "hectic." She recalled cases of malaria that had become "rampant" and progressed to seizures, and children who died convulsing. Since the vaccine arrived, she told AFP, "we have not recorded anything like the death of a child."
The regimen is four doses spread across the first 15 months of life. Children under five, whose immune systems are weaker, account for more than 75 per cent of malaria deaths in Africa, according to the World Health Organization. The vaccine's protection fades with time, but the aim is to cover children while they are most vulnerable. Hadiza Hussayn Jibril of the NGO PATH, which is supporting Bayelsa's rollout, called it a breakthrough but cautioned that it does not give 100 per cent protection. PATH reports an 18-percent drop in the share of Bayelsa children under five who have malaria at any given time. That gain is notable because bed net and preventive drug distribution in the state have lagged for years.
The national picture is more modest. Nigeria has 240 million people and 68.5 million infections a year, yet the jabs are only being given in four of its 36 states. The slow start has had some benefit: health workers have reduced dropout between doses and worked out how to reach remote communities. James Kurofou, director of immunisation for Sagbama local government area, described zones with no roads where staff must travel by boat. Speaking on the bank of one of the Niger Delta's wide, mud-coloured rivers, he said these are areas the service normally does not reach. Where parents, often those who could not afford the trip, missed appointments, workers began giving doses during home visits.
The setting underlines a wider problem. Bayelsa's mangroves and creeks are punctuated by armed men guarding oil pipelines. Muhammed Afolabi, co-director of the London School of Hygiene and Tropical Medicine's Vaccine Centre, noted that oil wealth does not automatically produce working primary health care, citing decades of corruption and underinvestment in Nigeria's health infrastructure. Fighting malaria also depends on a mix of state and private capacity to buy medicines, run public health campaigns and maintain drains and sewage. The Bayelsa health ministry did not respond to a request for comment.
At a ceremony in the state capital, Yenagoa, organised by PATH and local authorities, workers from Sagbama and Ogbia were thanked with singing and dancing in a meeting hall. Their gifts were practical: rubber boots, a raincoat and an umbrella for the long treks ahead. The next test is whether the vaccine can move beyond four states and into the places reachable only by boat.
Citations marquantes
We have not recorded anything like the death of a child.— Elizabeth Ogisi, director of primary health care, Ogbia local government area
The malaria vaccine is a breakthrough, but it doesn't provide 100 per cent protection.— Hadiza Hussayn Jibril, PATH
Envie de l'histoire complète ?
Lire l'original sur Malay Mail ↗